促销时间表 Ampio Pharmaceuticals, Inc.
先进的时间表
简单图表
关于公司
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It focuses on the preclinical development of AR-300, a novel proprietary, small molecule formulation for the treatment of osteoarthritis of the knee. The company is headquartered in Englewood, Colorado.
| Цена ао |
0.8115 |
| EBITDA |
-0.0222 |
| P/E |
1.46 |
| P/BV |
13.24 |
| EV/EBITDA |
-3.62 |
| Сайт |
https://ampiopharma.com
|
| Число акций ао |
0.0008101 млрд |
| Валюта |
usd |
| ISIN |
US03209T1097 |
| IPO date |
2010-03-31 |
| Sector |
Health Care |
| Industry |
Pharmaceuticals |
| Валюта отчета |
usd |
| 每日价格变化: |
0% (0.0022) |
| 每周价格变化: |
0% (0.0022) |
| 每月价格变化: |
0% (0.0022) |
| 3个月内价格变化: |
-97.8% (0.1) |
| 六个月内的价格变化: |
-99.76% (0.9212) |
| 每年价格变化: |
-99.94% (3.62) |
| 3年内价格变化: |
-99.87% (1.7) |
| 5年内价格变化: |
-99.52% (0.4552) |
| 年初以来价格变化: |
-99.92% (2.77) |
|
|
低估
| 姓名 |
意义 |
年级 |
| P/S |
0 |
0 |
| P/BV |
0.4629 |
10 |
| P/E |
0 |
0 |
| EV/EBITDA |
0.2438 |
10 |
| 全部的: |
|
5 |
|
效率
| 姓名 |
意义 |
年级 |
| ROA, % |
-150.49 |
0 |
| ROE, % |
-256.9 |
0 |
| 全部的: |
|
0 |
|
|
|
股息
| 姓名 |
意义 |
年级 |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| 全部的: |
|
0 |
|
责任
| 姓名 |
意义 |
年级 |
| Debt/EBITDA |
-0.0296 |
10 |
| 全部的: |
|
10 |
|
成长冲动
| 姓名 |
意义 |
年级 |
| 盈利能力 Revenue, % |
6099.8 |
10 |
| 盈利能力 Ebitda, % |
-58.25 |
0 |
| 盈利能力 EPS, % |
-41.84 |
0 |
| 全部的: |
|
2 |
|
| 导师 |
职称 |
支付 |
出生年份 |
| Mr. Michael A. Martino |
CEO, CFO, General Secretary & Director |
550k |
1957 (67 年) |
| Dr. David Bar-Or M.D. |
Founder & Chairman of Scientific Advisory Board |
145.6k |
1949 (75 年) |
| April Ramirez |
Clinical Trial Manager |
N/A |
|
